"The Samaritan Pastega Regional Cancer Center provides comprehensive care for all types of cancers. Services include medical oncology, radiation oncology, chemotherapy, onsite laboratory and lymphedema. Physicians, therapists, nurses, dosimetrists, social workers, physicists, dietitians and chaplains provide compassionate, individualized care. Additional support includes a hospitality house, a cancer resource center and clinical trials. The program partners with Stanford Cancer Center."

During the past decade, Samaritan Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samaritan Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Samaritan Regional Cancer Center" are "Brain and Central Nervous System Tumors" (1 trials), "Breast Cancer" (1 trials), "Head and Neck Cancer" (1 trials), "Metastatic Cancer" (1 trials) and "Oral Complications" (1 trials). Many other conditions were trialed in "Samaritan Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Samaritan Regional Cancer Center" are "Drug" (5 trials), "Radiation" (5 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "brachytherapy" (2 trials), "Placebo" (1 trials), "Talc" (1 trials), "carmustine" (1 trials) and "conventional surgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samaritan Regional Cancer Center" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Samaritan Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Samaritan Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samaritan Regional Cancer Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".